These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 24793757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker?
    Kim YK, Na KS, Hwang JA, Yoon HK, Lee HJ, Hahn SW, Lee BH, Jung HY.
    J Affect Disord; 2013 Nov; 151(2):738-743. PubMed ID: 24012102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glutamate-Related Antibodies and Peripheral Insulin-Like Growth Factor in Bipolar Disorder and Lithium Prophylaxis.
    Ferensztajn-Rochowiak E, Kaczmarek M, Wójcicka M, Kaufman-Szukalska E, Dziuda S, Remlinger-Molenda A, Szeliga-Neymann A, Losy J, Rybakowski JK.
    Neuropsychobiology; 2019 Nov; 77(1):49-56. PubMed ID: 30336492
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders.
    Lee BH, Kim YK.
    J Affect Disord; 2012 Jan; 136(1-2):181-184. PubMed ID: 21862441
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder.
    Inal-Emiroglu FN, Karabay N, Resmi H, Guleryuz H, Baykara B, Alsen S, Senturk-Pilan B, Akay A, Kose S.
    J Affect Disord; 2015 Aug 15; 182():50-6. PubMed ID: 25973783
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum angioneurin levels following electroconvulsive therapy for mood disorders.
    Zhang T, Tang X, Wei Y, Xu L, Hu Y, Cui H, Zeng J, Ye J, Xie Y, Tang Y, Liu H, Chen T, Li C, Liu X, Wang J.
    Bipolar Disord; 2023 Dec 15; 25(8):671-682. PubMed ID: 36871135
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients.
    Palomino A, González-Pinto A, Martinez-Cengotitabengoa M, Ruiz de Azua S, Alberich S, Mosquera F, Matute C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul 01; 44():29-33. PubMed ID: 23337034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brief psychoeducation for bipolar disorder: Evaluation of trophic factors serum levels in young adults.
    Wiener CD, Molina ML, Moreira FP, Dos Passos MB, Jansen K, da Silva RA, de Mattos Souza LD, Oses JP.
    Psychiatry Res; 2017 Nov 01; 257():367-371. PubMed ID: 28803094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z, Ozerdem A, Ceylan D, Yalçın Y, Can G, Resmi H, Akan P, Ergör G, Aydemir O, Cengisiz C, Kerim D.
    J Affect Disord; 2014 Sep 01; 166():193-200. PubMed ID: 25012431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.